Suppr超能文献

鉴定正常人类妊娠期间选择性溶解的合体滋养层细胞膜蛋白作为潜在抗原靶点。

Identification of selectively solubilised syncytiotrophoblast plasma membrane proteins as potential antigenic targets during normal human pregnancy.

作者信息

Davies M, Browne C M

出版信息

J Reprod Immunol. 1985 Aug;8(1):33-44. doi: 10.1016/0165-0378(85)90076-2.

Abstract

Syncytiotrophoblast plasma membranes prepared from term placentae were selectively solubilised in non-ionic detergents. The solubilised proteins and the insoluble residue were tested in an ELISA assay for their ability to function as antigenic targets for anti-trophoblast antibodies present in normal first trimester pregnancy sera. The soluble proteins were fractionated by gel filtration and four major antigen forms were identified. The antigens were reactive with affinity purified anti-trophoblast antibody isolated from maternal sera and hence were termed maternally-recognised trophoblast antigens (MRTA); these were designated MRTA-I (Mr = 400,000 D), MRTA-II (Mr = 142,000), MRTA-III (Mr = 50,000) and MRTA-IV (Mr = 13,000). The relationship between MRTA-I, II, III and IV and antigens identified in maternal sera in the form of immune complexes is discussed.

摘要

从足月胎盘制备的合体滋养层细胞质膜在非离子型去污剂中被选择性溶解。将溶解的蛋白质和不溶性残渣在酶联免疫吸附测定(ELISA)中进行测试,以检测它们作为正常妊娠早期血清中抗滋养层抗体的抗原靶点的功能能力。通过凝胶过滤对可溶性蛋白质进行分级分离,并鉴定出四种主要的抗原形式。这些抗原与从母体血清中分离出的亲和纯化抗滋养层抗体发生反应,因此被称为母体识别的滋养层抗原(MRTA);它们分别被命名为MRTA-I(分子量 = 400,000道尔顿)、MRTA-II(分子量 = 142,000)、MRTA-III(分子量 = 50,000)和MRTA-IV(分子量 = 13,000)。本文讨论了MRTA-I、II、III和IV与以免疫复合物形式在母体血清中鉴定出的抗原之间的关系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验